Download
1 / 4
40 likes | 43 Views
The findings reviewed by GME stated that the Global Ophthalmology Drugs & Devices Market will expand with a CAGR value of 5.9 percent from 2021 to 2026. Increasing incidences of eyesight disorders and the growing geriatric population associated with cataract disorder are expected to contribute to the growth of ophthalmology devices and drugs market.<br>Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and in-depth TOC on "Ophthalmology Drugs & Devices Market - Forecast to 2026" <br>https://www.globalmarketestimates.com/market-report/global-ophthalmology-drugs-devices-market-2914<br>By Product (Diagnostic and Monitoring Devices [Optical Coherence Tomographers (OCT), Ophthalmic Ultrasound Imaging Systems, Fundus Cameras, Ophthalmoscopes, tRetinoscopes, tWavefront Aberrometer, Corneal Topographer, Autorefractors/Phoropters, Pachymeters, Keratometers, Specular Microscopes, Biometers, Visual Field Analyzers/Perimeter, Tonometers, Slit Lamps, Optotype Projectors, Dioptometers], Surgical Devices [Cataract {Intraocular Lens (IOL), Ophthalmic Viscoelastic Devices (OVD), Phacoemulsification Devices}, Glaucoma {Glaucoma Drainage Devices (GDD), Stents and Implants, Glaucoma Lasers, Glaucoma Systems}, Refractive Error {Excimer Laser, YAG Laser, Microkeratome, Femtosecond Laser}, Vitreoretinal {Vitrectomy Machines, Photocoagulation Lasers, Illumination Devices}], Vision Care [Contact Lenses, Spectacles], Drugs [Existing Treatment Drugs, Drugs in Pipeline]), By Indication (Glaucoma, Retinal Disorders [Age-related Macular Degeneration (AMD), Diabetic Retinopathy, Macular Edema] Dry Eye, Allergy/Inflammation/Conjunctivitis) By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis<br> Key Market Insights<br>u2022tOphthalmology drugs & devices are used to correct eyesight disorders and restore vision and hence this market will be growing rapidly during the forecast period<br>u2022tThe increasing instances of eyesight disorders and the growing number of diabetes patients are expected to increase the demand for ophthalmology devices and drugs.<br>u2022tThe largest shareholder of the ophthalmology drugs & devices market is the vision care segment in 2020 as per the product type outlook<br>u2022tTopcon (Japan), Allergan (U.S.), Alcon (U.S.), Merck (U.S.), Roche (Switzerland), Pfizer (U.S.), Santen (Japan), Bausch & Lomb, Inc. (U.S.), Abbott Medical Optics (U.S.), Carl Zeiss Meditec (Germany), Johnson & Johnson (U.S.), ), Essilor (France), and Nidek (Japan), among others, are the major vendors competing in the ophthalmology drugs & devices market.<br>Browse the Report @ https://www.globalmarketestimates.com/market-report/global-ophthalmology-drugs-devices-market-2914<br>Product Outlook (Revenue, USD Billion, 2021-2026)<br>u2022tDiagnostic and Monitoring Devices<br>u2022tOptical Coherence Tomographers (OCT)<br>u2022tOphthalmic Ultrasound Imaging Systems<br>u2022tFundus Cameras<br>u2022tOphthalmoscopes<br>u2022tRetinoscopes<br>u2022tWavefront Aberrometer <br>u2022tCorneal Topographer <br>u2022tAutorefractors/Phoropters<br>u2022tPachymeters<br>u2022tKeratometers<br>u2022tSpecular Microscopes<br>u2022tBiometers<br>u2022tVisual Field Analyzers/Perimeter<br>u2022tTonometers<br>u2022tSlit Lamps<br>u2022tOptotype Projectors<br>u2022tDioptometers<br>u2022tVision Care<br>u2022tContact Lenses<br>u2022tSpectacles<br>u2022tSurgical Devices<br>u2022tCataracts<br>uf0a7tIntraocular Lens (IOL)<br>uf0a7tOphthalmic Viscoelastic Devices (OVD)<br>uf0a7tPhacoemulsification Devices<br>u2022tGlaucoma <br>uf0a7tGlaucoma Drainage Devices (GDD)<br>uf0a7tStents and Implants<br>uf0a7tGlaucoma Lasers<br>uf0a7tGlaucoma Systems<br>u2022tRefractive Error<br>uf0a7tExcimer Laser<br>uf0a7tYAG Laser<br>uf0a7tMicrokeratome<br>uf0a7tFemtosecond Laser<br>u2022tVitreoretinal<br>uf0a7tVitrectomy Machines<br>uf0a7tPhotocoagulation Lasers<br>uf0a7tIllumination Devices<br>Indication Outlook (Revenue, USD Billion, 2021-2026)<br>u2022tGlaucoma<br>u2022tRetinal Disorders (Age-Related Macular Degeneration (AMD), Diabetic Retinopathy, Macular Edema)<br>u2022tDry Eye<br>u2022tAllergy/Inflammation/Conjunctivitis<br>Regional Outlook (Revenue, USD Billion, 2021-2026)<br>North Americat<br>u2022tThe U.S.<br>u2022tCanada<br>u2022tMexico<br>Europe<br>u2022tGermany<br>u2022tUK<br>u2022tFrance<br>u2022tSpain<br>u2022tItaly<br>u2022tRest of Europe<br>Asia Pacific<br>u2022tChina<br>u2022tIndia<br>u2022tJapan<br>u2022tSouth Korea<br>u2022tAustralia<br>u2022tRest of APAC<br>Central & South America<br>u2022tBrazil<br>u2022tArgentina<br>u2022tRest of CSA<br>Middle East & Africa<br>u2022tSaudi Arabia<br>u2022tUAE<br>u2022tRest of MEA<br><br>Contact: Tracy Simon<br>Email address: tracy.simon@globalmarketestimates.com<br>Phone Number: 16026667238<br>Website: https://www.globalmarketestimates.com/<br>Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php<br><br><br><br>
E N D
Ophthalmology Drugs & Devices Market– Forecasts to 2026 The findings reviewed by GME stated that the Global Ophthalmology Drugs & Devices Market will expand with a CAGR value of 5.9 percent from 2021 to 2026. Increasing incidences of eyesight disorders and the growing geriatric population associated with cataract disorder are expected to contribute to the growth of ophthalmology devices and drugs market. Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and in-depth TOC on "Ophthalmology Drugs & Devices Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-ophthalmology-drugs-devices-market-2914 By Product (Diagnostic and Monitoring Devices [Optical Coherence Tomographers (OCT), Ophthalmic Ultrasound Imaging Systems, Fundus Cameras, Ophthalmoscopes, Retinoscopes, Wavefront Aberrometer, Corneal Topographer, Autorefractors/Phoropters, Pachymeters, Keratometers, Specular Microscopes, Biometers, Visual Field Analyzers/Perimeter, Tonometers, Slit Lamps, Optotype Projectors, Dioptometers], Surgical Devices [Cataract {Intraocular Lens (IOL), Ophthalmic Viscoelastic Devices (OVD), Phacoemulsification Devices}, Glaucoma {Glaucoma Drainage Devices (GDD), Stents and Implants, Glaucoma Lasers, Glaucoma Systems}, Refractive Error {Excimer Laser, YAG Laser, Microkeratome, Femtosecond Laser}, Vitreoretinal {Vitrectomy Machines, Photocoagulation Lasers, Illumination Devices}], Vision Care [Contact Lenses, Spectacles], Drugs [Existing Treatment Drugs, Drugs in Pipeline]), By Indication (Glaucoma, Retinal Disorders [Age-related Macular Degeneration (AMD), Diabetic Retinopathy, Macular Edema] Dry Eye, Allergy/Inflammation/Conjunctivitis) By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis Key Market Insights •Ophthalmology drugs & devices are used to correct eyesight disorders and restore vision and hence this market will be growing rapidly during the forecast period •The increasing instances of eyesight disorders and the growing number of diabetes patients are expected to increase the demand for ophthalmology devices and drugs. •The largest shareholder of the ophthalmology drugs & devices market is the vision care segment in 2020 as per the product type outlook •Topcon (Japan), Allergan (U.S.), Alcon (U.S.), Merck (U.S.), Roche (Switzerland), Pfizer (U.S.), Santen (Japan), Bausch & Lomb, Inc. (U.S.), Abbott Medical Optics (U.S.), Carl Zeiss Meditec (Germany),
Johnson & Johnson (U.S.), ), Essilor (France), and Nidek (Japan), among others, are the major vendors competing in the ophthalmology drugs & devices market. Browse the Report @ https://www.globalmarketestimates.com/market-report/global-ophthalmology-drugs- devices-market-2914 Product Outlook (Revenue, USD Billion, 2021-2026) •Diagnostic and Monitoring Devices •Optical Coherence Tomographers (OCT) •Ophthalmic Ultrasound Imaging Systems •Fundus Cameras •Ophthalmoscopes •Retinoscopes •Wavefront Aberrometer •Corneal Topographer •Autorefractors/Phoropters •Pachymeters •Keratometers •Specular Microscopes •Biometers •Visual Field Analyzers/Perimeter •Tonometers •Slit Lamps •Optotype Projectors •Dioptometers •Vision Care •Contact Lenses •Spectacles •Surgical Devices •Cataracts ▪Intraocular Lens (IOL) ▪Ophthalmic Viscoelastic Devices (OVD) ▪Phacoemulsification Devices •Glaucoma ▪Glaucoma Drainage Devices (GDD) ▪Stents and Implants ▪Glaucoma Lasers ▪Glaucoma Systems •Refractive Error
▪Excimer Laser ▪YAG Laser ▪Microkeratome ▪Femtosecond Laser •Vitreoretinal ▪Vitrectomy Machines ▪Photocoagulation Lasers ▪Illumination Devices Indication Outlook (Revenue, USD Billion, 2021-2026) •Glaucoma •Retinal Disorders (Age-Related Macular Degeneration (AMD), Diabetic Retinopathy, Macular Edema) •Dry Eye •Allergy/Inflammation/Conjunctivitis Regional Outlook (Revenue, USD Billion, 2021-2026) North America •The U.S. •Canada •Mexico Europe •Germany •UK •France •Spain •Italy •Rest of Europe Asia Pacific •China •India •Japan •South Korea •Australia
•Rest of APAC Central & South America •Brazil •Argentina •Rest of CSA Middle East & Africa •Saudi Arabia •UAE •Rest of MEA Contact: Tracy Simon Email address: tracy.simon@globalmarketestimates.com Phone Number: +16026667238 Website: https://www.globalmarketestimates.com/ Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php
